Provided by Tiger Trade Technology Pte. Ltd.

Insulet

145.13
+1.721.20%
Post-market: 145.130.00000.00%19:38 EDT
Volume:1.04M
Turnover:151.66M
Market Cap:10.05B
PE:27.40
High:146.67
Open:144.20
Low:143.81
Close:143.41
52wk High:354.88
52wk Low:126.40
Shares:69.26M
Float Shares:69.07M
Volume Ratio:0.73
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.30
EPS(LYR):3.48
ROE:26.02%
ROA:9.71%
PB:7.07
PE(LYR):41.71

Loading ...

TD Cowen Adjusts Insulet Price Target to $144 From $294

MT Newswires Live
·
Aug 06

Insulet price target lowered to $175 from $248 at Baird

TIPRANKS
·
Aug 06

Insulet price target lowered to $180 from $190 at Deutsche Bank

TIPRANKS
·
Aug 06

Leerink downgrades Insulet to Market Perform, lowers target to $145

TIPRANKS
·
Aug 06

Analysts Conflicted on These Healthcare Names: Aurora Cannabis (ACB), Biodesix (BDSX) and Insulet (PODD)

TIPRANKS
·
Aug 06

Insulet Corporation : Raymond James Cuts Target Price to $180 from $216

THOMSON REUTERS
·
Aug 06

These Analysts Slash Their Forecasts On Insulet After Q2 Results

Benzinga Earnings
·
Aug 06

Insulet Corporation : Leerink Partners Cuts to Market Perform from Outperform; Cuts Target Price to $145 from $247

THOMSON REUTERS
·
Aug 06

Insulet Cut to Hold from Buy by Truist Securities

Dow Jones
·
Aug 06

Insulet downgraded to Neutral from Buy at BTIG

TIPRANKS
·
Aug 06

Insulet downgraded to Neutral from Overweight at JPMorgan

TIPRANKS
·
Aug 06

Insulet Corporation : JP Morgan Cuts to Neutral from Overweight; Cuts Target Price to $152 from $275

THOMSON REUTERS
·
Aug 06

Insulet Earnings Call: Growth Intact Amid Type 2 Reset

TIPRANKS
·
Aug 06

Insulet downgraded to Equal Weight from Overweight at Wells Fargo

TIPRANKS
·
Aug 06

KORU Medical Q2 Returns to Profit on Lower Manufacturing Costs and Higher Average Selling Prices

Reuters
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Insulet (PODD), ImageneBio (IMA) and InMode (INMD)

TIPRANKS
·
Aug 06

Insulet Corp. Stock Sheds 20.1%, Underperforms Peers

Dow Jones
·
Aug 06

Solventum Q2 Sales, Adjusted EPS Beat Estimates; FY Outlook Lifted

Reuters
·
Aug 06

Nyxoah Q2 Revenue Surges on U.S. Growth, but Margins Drop

Reuters
·
Aug 06

This Medtech Beat Earnings, but the Stock is Having Its Worst Day in 17 Years

Dow Jones
·
Aug 06